首页> 美国卫生研究院文献>Cancer Cell International >Collapsin response mediator protein 4 promotor methylation level as a potential predictor for diagnosing primary malignant lymphoma of the prostate
【2h】

Collapsin response mediator protein 4 promotor methylation level as a potential predictor for diagnosing primary malignant lymphoma of the prostate

机译:胶原蛋白介导蛋白4启动子的甲基化水平可作为诊断前列腺原发性恶性淋巴瘤的潜在指标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPrimary malignant lymphoma of the prostate (PMLP) is prone to occur in the elderly, and it has no significant correlation with lactate dehydrogenase (LDH) and prostate specific antigen (PSA). Clinical symptoms and imaging data of PMLP remain unspecific, and its prognosis is poor. A previous result showed that collapsin response mediator protein 4 (CRMP4) promotor methylation can be used as a predictor for lymph node metastases in prostate biopsies. However, the relationship between CRMP4 promotor methylation and PMLP has not been studied.
机译:背景前列腺原发性恶性淋巴瘤(PMLP)易于在老年人中发生,并且与乳酸脱氢酶(LDH)和前列腺特异性抗原(PSA)没有显着相关性。 PMLP的临床症状和影像学数据仍不确定,其预后较差。先前的结果表明,胶原蛋白反应介质蛋白4(CRMP4)启动子甲基化可以用作前列腺活检中淋巴结转移的预测因子。但是,尚未研究CRMP4启动子甲基化与PMLP之间的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号